Movement Alert｜BIOCYTOGEN-B Declines 5.03% in Regular Trading, CMB International Major Stake Reduction Continues to Weigh on Sentiment

Market Focus07-29

On July 29, BIOCYTOGEN-B fell 5.03% in regular trading, trading at 52.05 HKD/share, with turnover of approximately 38.17 million HKD. The stock extended its prior-session losses as selling pressure from a major shareholder's concentrated disposal continued to suppress market confidence.

On the news front, CMB International Financial Holdings and its affiliates — including CMB International Investment Management Limited, Astral Eminent Limited, and CMBI Private Equity Series SPC — sold a combined 1.0925 million shares on July 21 at an average price of 54.4237 HKD, involving approximately 59.46 million HKD. Following the disposal, the group's long position declined from 11.94% to 10.95%. The concentrated reduction by a significant institutional holder has exerted sustained downward pressure on the share price across consecutive sessions.

Meanwhile, the broader biotechnology sector remained under pressure, with peers including Keymed Biosciences-B down 3.46%, SKB Bio down 3.21%, and Innovent Biologics down 1.28%, reflecting continued sector-wide weakness in innovative drug names.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1129690917?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-29 13:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129690917","market":"us","top_or_hot":-1,"title":"Movement Alert｜BIOCYTOGEN-B Declines 5.03% in Regular Trading, CMB International Major Stake Reduction Continues to Weigh on Sentiment","media":"Market Focus","content":"<p><p>On July 29, BIOCYTOGEN-B fell 5.03% in regular trading, trading at 52.05 HKD/share, with turnover of approximately 38.17 million HKD. The stock extended its prior-session losses as selling pressure from a major shareholder's concentrated disposal continued to suppress market confidence.</p><p>On the news front, CMB International Financial Holdings and its affiliates — including CMB International Investment Management Limited, Astral Eminent Limited, and CMBI Private Equity Series SPC — sold a combined 1.0925 million shares on July 21 at an average price of 54.4237 HKD, involving approximately 59.46 million HKD. Following the disposal, the group's long position declined from 11.94% to 10.95%. The concentrated reduction by a significant institutional holder has exerted sustained downward pressure on the share price across consecutive sessions.</p><p>Meanwhile, the broader biotechnology sector remained under pressure, with peers including Keymed Biosciences-B down 3.46%, SKB Bio down 3.21%, and Innovent Biologics down 1.28%, reflecting continued sector-wide weakness in innovative drug names.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜BIOCYTOGEN-B Declines 5.03% in Regular Trading, CMB International Major Stake Reduction Continues to Weigh on Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜BIOCYTOGEN-B Declines 5.03% in Regular Trading, CMB International Major Stake Reduction Continues to Weigh on Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-29 13:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 29, BIOCYTOGEN-B fell 5.03% in regular trading, trading at 52.05 HKD/share, with turnover of approximately 38.17 million HKD. The stock extended its prior-session losses as selling pressure from a major shareholder's concentrated disposal continued to suppress market confidence.</p><p>On the news front, CMB International Financial Holdings and its affiliates — including CMB International Investment Management Limited, Astral Eminent Limited, and CMBI Private Equity Series SPC — sold a combined 1.0925 million shares on July 21 at an average price of 54.4237 HKD, involving approximately 59.46 million HKD. Following the disposal, the group's long position declined from 11.94% to 10.95%. The concentrated reduction by a significant institutional holder has exerted sustained downward pressure on the share price across consecutive sessions.</p><p>Meanwhile, the broader biotechnology sector remained under pressure, with peers including Keymed Biosciences-B down 3.46%, SKB Bio down 3.21%, and Innovent Biologics down 1.28%, reflecting continued sector-wide weakness in innovative drug names.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02315","symbol_name":"百奥赛图-B","start_time":0,"source_url":"","article_id":"1129690917","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129690917","pubTimestamp":1785303759,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 29, BIOCYTOGEN-B fell 5.03% in regular trading, trading at 52.05 HKD/share, with turnover of approximately 38.17 million HKD. The stock extended its prior-session losses as selling pressure...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02315":"百奥赛图-B"},"translate_title":"走势提醒|BIOCYTOGEN-B常规交易下跌5.03%，招银国际重大减持继续打压市场情绪","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02315":1},"content_text":"On July 29, BIOCYTOGEN-B fell 5.03% in regular trading, trading at 52.05 HKD/share, with turnover of approximately 38.17 million HKD. The stock extended its prior-session losses as selling pressure from a major shareholder's concentrated disposal continued to suppress market confidence.On the news front, CMB International Financial Holdings and its affiliates — including CMB International Investment Management Limited, Astral Eminent Limited, and CMBI Private Equity Series SPC — sold a combined 1.0925 million shares on July 21 at an average price of 54.4237 HKD, involving approximately 59.46 million HKD. Following the disposal, the group's long position declined from 11.94% to 10.95%. The concentrated reduction by a significant institutional holder has exerted sustained downward pressure on the share price across consecutive sessions.Meanwhile, the broader biotechnology sector remained under pressure, with peers including Keymed Biosciences-B down 3.46%, SKB Bio down 3.21%, and Innovent Biologics down 1.28%, reflecting continued sector-wide weakness in innovative drug names.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1129690917","isCrawlerRequest":true}